Synopsys Beats Revenue Amid AI-Fueled Chip Demand Surge
Synopsys topped earnings and revenue expectations as AI-fueled chip design demand remains strong. Yet softer Q2 guida...
This guide highlights the most trusted stablecoins based on reserves, audits, and transparency to help you choose confidently.
19,370 articlesSynopsys topped earnings and revenue expectations as AI-fueled chip design demand remains strong. Yet softer Q2 guida...
A major strategic bet on U.S. manufacturing, taiwan semiconductor commits investing another $100B in the United State...
Looking at Royal Caribbean in 2026, investors want clarity: is it a buy, hold, or sell? This guide breaks down the ca...
When a Federal Reserve chair signals a preference for policy stability over boom-and-bust cycles, it can upend how in...
Solventum wraps up 2025 with meaningful growth and a clearer path to profitability. This article breaks down the numb...
A perplexing Friday drop in Coca-Cola stock raised questions about cybersecurity, earnings risk, and how to react to ...
Singapore's ComfortDelGro is weighing robotaxi deployments in London as it reports record 2025 revenue, underscoring ...
Investors turn to a resilient, income-focused mix to weather headlines and market swings in 2026. A practical framewo...
As 1stdibs gears up for 2025 earnings, investors crave clarity on growth, profitability, and sustainable margins. Thi...
Interactive Brokers grew customer accounts by 34% in the last year, signaling strong momentum in a competitive discou...
February delivered a chilly stretch for investors as inflation concerns and AI headlines weighed on stock prices. Thi...
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...